It’s Asthma and Allergy Awareness Month and the seasonal allergies category is as congested as ever. But a slew of patent expirations poses a greater concern than the fierce competition.
While the overall US pharmaceuticals market grew modestly in 2007, product exclusivity and safety issues continued to weigh heavily on the industry. MM&M charts the trends, products and numbers of the companies that came out on top
On reimbursement, early bird gets the sales, says Elan’s Tillman
Reimbursement strategy is a key component of a successful launch, especially with biologics. Sales, revenue and customer behavior all depend on it, explains Randi Tillman, senior director, pricing and reimbursement strategies at Elan.